Article
Human T-cell recognition of synthetic peptides representing conserved and variant sequences from the merozoite surface protein 2 of Plasmodium falciparum.
Immunology letters - 1 Jun 1997
Theander T G, Hviid L, Dodoo D, Afari E A, Jensen J B, Rzepczyk C M
Abstract excerpt
Merozoite surface protein 2 (MSP2) is a malaria vaccine candidate currently undergoing clinical trials. We analyzed the peripheral blood mononuclear cell (PBMC) response to synthetic peptides corresponding to conserved and variant regions of the FCQ-27 allelic form of MSP2 in Ghanaian individuals from an area of hyperendemic malaria transmission and in Danes without exposure to malaria. PBMC from 20-39% of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
